NEW YORK, Nov 13 - SC Biosciences, a subsidiary of Japan’s $103 billion trading giant Sumitomo, has penned a deal to explore market opportunities for Viaken’s informatics products and services in Japan, the companies announced Monday.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.